Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARIPIPRAZOLE Cause Neutrophil count increased? 149 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Neutrophil count increased have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.2% of all adverse event reports for ARIPIPRAZOLE.

149
Reports of Neutrophil count increased with ARIPIPRAZOLE
0.2%
of all ARIPIPRAZOLE reports
75
Deaths
110
Hospitalizations

How Dangerous Is Neutrophil count increased From ARIPIPRAZOLE?

Of the 149 reports, 75 (50.3%) resulted in death, 110 (73.8%) required hospitalization, and 20 (13.4%) were considered life-threatening.

Is Neutrophil count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 149 reports have been filed with the FAERS database.

What Other Side Effects Does ARIPIPRAZOLE Cause?

Drug ineffective (5,566) Off label use (5,473) Product use in unapproved indication (4,792) Weight increased (4,636) Anxiety (3,076) Suicide attempt (2,796) Suicidal ideation (2,618) Condition aggravated (2,157) Insomnia (2,147) Akathisia (2,107)

What Other Drugs Cause Neutrophil count increased?

CLOZAPINE (3,125) PREDNISONE (365) RITUXIMAB (346) CLOZARIL (224) OLANZAPINE (220) METHYLPREDNISOLONE (202) CYCLOPHOSPHAMIDE (177) ADALIMUMAB (175) ALEMTUZUMAB (171) PACLITAXEL (159)

Which ARIPIPRAZOLE Alternatives Have Lower Neutrophil count increased Risk?

ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL ARIPIPRAZOLE vs ARIXTRA ARIPIPRAZOLE vs ARMODAFINIL ARIPIPRAZOLE vs AROMASIN ARIPIPRAZOLE vs ARSENIC TRIOXIDE

Related Pages

ARIPIPRAZOLE Full Profile All Neutrophil count increased Reports All Drugs Causing Neutrophil count increased ARIPIPRAZOLE Demographics